1 day+0.17%
1 week+0.17%
Current month+9.09%
1 month+1.69%
6 months-14.29%
Current year+9.49%
1 week 1,100
Extreme 1100
1,200
1 month 1,063
Extreme 1063
1,384
Current year 805
Extreme 805
1,600
1 year 805
Extreme 805
1,600
3 years 805
Extreme 805
2,390
5 years 805
Extreme 805
4,500
10 years 805
Extreme 805
7,430
Manager TitleAgeSince
Chief Executive Officer 64 -
Chief Tech/Sci/R&D Officer 61 24/03/2025
Corporate Officer/Principal 60 -
Director TitleAgeSince
Director/Board Member 64 -
Director/Board Member 60 -
Director/Board Member 61 24/03/2025
Change 5-day change 1-year change 3-year change Capi.($)
+0.17%+0.17%+9.49%-40.00% 4.95M
+0.13%+2.65%+65.61%+114.28% 1,055B
+0.20%+0.46%+52.60%+69.24% 654B
-0.29%+0.14%+20.96%+70.93% 467B
-0.85%+0.98%+41.29%+44.38% 348B
+0.71%+4.08%+22.24%+29.51% 275B
+1.23%+0.42%+14.57%+12.13% 258B
+2.11%+7.51%+52.89%+55.37% 224B
+0.83%+0.55%+35.99%+101.70% 187B
0.00%-10.14%-29.94%-60.30% 171B
Average +0.34%+1.41%+28.57%+39.72% 363.84B
Weighted average by Cap. +0.02%+1.67%+41.54%+67.83%

Financials

2014 2015
Net sales 6.45B 8,754B 5.66B 5.34B 4.87B 9.12B 618B 9.18B 63.96B 24.77B 316B 24.21B 23.69B 1,015B 7.28B 9,884B 6.39B 6.03B 5.5B 10.29B 698B 10.37B 72.21B 27.97B 357B 27.34B 26.75B 1,146B
Net income 155M 211B 136M 129M 117M 219M 14.88B 221M 1.54B 596M 7.6B 583M 570M 24.43B -1.32B -1,793B -1.16B -1.09B -998M -1.87B -127B -1.88B -13.1B -5.07B -64.69B -4.96B -4.85B -208B
Net Debt - -
Logo Genotech Corporation
Genotech Corporation is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company operates its business through three segments. Bio-Phamaceutical segment is involved in the manufacturing and sale of the main ingredients of finished pharmaceuticals such as antibiotics and immunosuppressants. Deoxyribonucleic Acid (DNA) & Ribonucleic Acid (RNA) Synthesis segment is involved in the manufacturing and sale of materials for biotechnology research including gene manipulation, polymerase chain reaction (PCR), cloning, and sequencing. Genome Analysis Service segment is involved in the analysis of the gene sequences of the samples requested by customers and the provision of analysis results.
Employees
-
Date Price Change Volume
21/09/26 KRW 1,200.00 +0.17% 11
18/09/26 KRW 1,198.00 -4.16% 12
  1. Stock Market
  2. Stocks
  3. A066830 Stock